AXOGEN INC (AXGN) Stock Price & Overview
NASDAQ:AXGN • US05463X1063
Current stock price
The current stock price of AXGN is 33.05 USD. Today AXGN is up by 0.64%. In the past month the price decreased by -1.17%. In the past year, price increased by 85.33%.
AXGN Key Statistics
- Market Cap
- 1.715B
- P/E
- 113.97
- Fwd P/E
- 63.63
- EPS (TTM)
- 0.29
- Dividend Yield
- N/A
AXGN Stock Performance
AXGN Stock Chart
AXGN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to AXGN. When comparing the yearly performance of all stocks, AXGN is one of the better performing stocks in the market, outperforming 91.16% of all stocks.
AXGN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AXGN. AXGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AXGN Earnings
On February 24, 2026 AXGN reported an EPS of 0.07 and a revenue of 59.90M. The company missed EPS expectations (-29.35% surprise) and missed revenue expectations (-0.64% surprise).
AXGN Forecast & Estimates
17 analysts have analysed AXGN and the average price target is 38.11 USD. This implies a price increase of 15.31% is expected in the next year compared to the current price of 33.05.
For the next year, analysts expect an EPS growth of 79.12% and a revenue growth 17.92% for AXGN
AXGN Groups
Sector & Classification
AXGN Financial Highlights
Over the last trailing twelve months AXGN reported a non-GAAP Earnings per Share(EPS) of 0.29. The EPS increased by 123.08% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.08% | ||
| ROE | -12.19% | ||
| Debt/Equity | 0.38 |
AXGN Ownership
AXGN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.17 | 191.058B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.86 | 171.691B | ||
| SYK | STRYKER CORP | 23.37 | 133.773B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.16 | 103.561B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.95 | 48.532B | ||
| IDXX | IDEXX LABORATORIES INC | 40.17 | 46.687B | ||
| BDX | BECTON DICKINSON AND CO | 11.87 | 45.635B | ||
| RMD | RESMED INC | 19.07 | 33.595B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.25 | 32.892B | ||
| DXCM | DEXCOM INC | 26.59 | 25.532B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.09 | 18.254B | ||
| HOLX | HOLOGIC INC | 15.31 | 16.777B | ||
| PODD | INSULET CORP | 35.25 | 15.816B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AXGN
Company Profile
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 622 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
Company Info
IPO: 1986-12-17
AXOGEN INC
13631 Progress Blvd., Suite 400
Alachua FLORIDA 32615 US
CEO: Karen Zaderej
Employees: 622
Phone: 13864626817
AXOGEN INC / AXGN FAQ
What does AXGN do?
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 622 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
What is the current price of AXGN stock?
The current stock price of AXGN is 33.05 USD. The price increased by 0.64% in the last trading session.
Does AXGN stock pay dividends?
AXGN does not pay a dividend.
How is the ChartMill rating for AXOGEN INC?
AXGN has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is AXOGEN INC (AXGN) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AXGN.
Can you provide the market cap for AXOGEN INC?
AXOGEN INC (AXGN) has a market capitalization of 1.72B USD. This makes AXGN a Small Cap stock.
What is the outstanding short interest for AXOGEN INC?
The outstanding short interest for AXOGEN INC (AXGN) is 5.84% of its float.